Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXN1GG
|
||||
| Drug Name |
5-(2-diethylamino-ethoxy)-7,12-dioxo-7,12-dihydro-dinaphtho[1,2-b;2',3'-d]furan-6-carboxylic acid methyl ester
|
||||
| Synonyms |
CHEMBL202162
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C28H25NO6
|
||||
| Canonical SMILES |
CCN(CC)CCOc1c(C(=O)OC)c2c3C(=O)c4ccccc4C(=O)c3oc2c5ccccc15
|
||||
| InChI |
InChI=1S/C28H25NO6/c1-4-29(5-2)14-15-34-25-18-12-8-9-13-19(18)26-20(22(25)28(32)33-3)21-23(30)16-10-6-7-11-17(16)24(31)27(21)35-26/h6-13H,4-5,14-15H2,1-3H3
|
||||
| InChIKey |
OHYFDYUPUPHUDP-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Epidermal growth factor receptor III | Target Info | [1587926] | ||
| Basic fibroblast growth factor receptor 1 | Target Info | [1587926] | |||
| KEGG Pathway | MAPK signaling pathway | ||||
| Ras signaling pathway | |||||
| Rap1 signaling pathway | |||||
| PI3K-Akt signaling pathway | |||||
| Adherens junction | |||||
| Signaling pathways regulating pluripotency of stem cells | |||||
| Regulation of actin cytoskeleton | |||||
| Pathways in cancer | |||||
| Proteoglycans in cancer | |||||
| Prostate cancer | |||||
| Melanoma | |||||
| Central carbon metabolism in cancer | |||||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Angiogenesis | ||||
| FGF signaling pathway | |||||
| Pathway Interaction Database | Glypican 1 network | ||||
| Syndecan-4-mediated signaling events | |||||
| N-cadherin signaling events | |||||
| FGF signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.